Dendynamics is an innovative company at the intersection of artificial intelligence (AI) and life sciences, focusing specifically on dendritic cells—crucial immune cells that are essential for initiating and regulating the body’s immune responses.
The company aims to harness its expertise in dendritic cell biology alongside advanced computational techniques to create groundbreaking treatments and diagnostics for various diseases. By leveraging machine learning and other AI technologies, Dendynamics analyzes complex biological data, formulates novel therapeutic strategies, and develops personalized medical approaches tailored to individual patient needs.
Scientific Description for Professional and Clinical Use
1. General Overview
CARBON-405™ is a next-generation topical therapy based on a low-molecular-weight, bioavailable compound CARBON-405, which reactivates dormant hair follicle stem cells by modulating mitochondrial metabolism. Unlike traditional anti-androgenic treatments, FollicoNOVA™ works independently of hormonal pathways, instead targeting cellular energy and follicular proliferation.
2. Mechanism of Action
The primary molecular target of CARBON-405 is the mitochondrial pyruvate carrier (MPC1/2 complex), which regulates the transport of pyruvate into mitochondria, determining the cell’s energetic status.
By reversibly inhibiting MPC:
Glycolytic activity increases
mTORC1 and β-catenin pathways are activated
Quiescent stem cells exit dormancy
Hair follicles shift from telogen to anagen phase
3. Composition (abbreviated INCI-style)
Component
Function
CARBON-405 (5-N-methyl-pyridone analog) 0.05%
Activates follicular growth via metabolic stimulation
Coenzyme Q10
Mitochondrial support and antioxidant
Niacinamide (Vitamin B3)
Enhances microcirculation
Copper Tripeptide-1
Stimulates angiogenesis and tissue remodeling
Liposomal carrier system
Nano-delivery of active ingredients
Panthenol, Allantoin
Soothing, anti-inflammatory agents
4. Preclinical Studies
Model: 3D human hair follicle organoids (in vitro)
+52% increase in Ki-67 expression (proliferation marker)
+47% improvement in mitochondrial membrane potential
−38% reduction in quiescence markers (p21, BMP6)
Model: C57BL/6 mice
Transition to anagen observed within 4 days of application
2.3× increase in hair shaft length vs. placebo
No signs of irritation or systemic toxicity
5. Clinical Trials
Phase I (n=20, males and females, 18–45 y/o):
Daily application of 0.05% CARBON-405™ for 7 days
No local or systemic adverse effects reported
Biopsy confirmed +43% increase in stem cell proliferation markers
34% of men and 28% of women showed >20% increase in hair density
41% showed an increase in terminal hair count
0% treatment discontinuation due to side effects
6. Conclusion and Clinical Potential
CARBON-405™ is the first-in-class metabolic hair restoration agent that stimulates natural follicular regrowth by reactivating mitochondrial pathways. Unlike hormonal or vascular-based treatments (e.g., minoxidil, finasteride), it delivers sustainable results without systemic absorption or endocrine side effects.
Indications for Use
Androgenetic alopecia (Stages I–III, male and female)
